Perspective Therapeutics (CATX) Gross Margin Growth (5y) (2015 - 2023)
Perspective Therapeutics (CATX) Gross Margin Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 387.29 Mn | 387.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,957.00 |
| Sep 30, 2023 | 23.00 |
| Jun 30, 2023 | -1,110.00 |
| Mar 31, 2023 | -1,511.00 |
| Sep 30, 2022 | 1,711.00 |
| Jun 30, 2022 | 736.00 |
| Mar 31, 2022 | 2,666.00 |
| Dec 31, 2021 | 4,342.00 |
| Sep 30, 2021 | 3,569.00 |
| Jun 30, 2021 | 5,395.00 |
| Mar 31, 2021 | 4,688.00 |
| Dec 31, 2020 | 4,695.00 |
| Sep 30, 2020 | 4,568.00 |
| Jun 30, 2020 | 3,171.00 |
| Mar 31, 2020 | 5,447.00 |
| Dec 31, 2019 | 5,393.00 |
| Sep 30, 2019 | 5,865.00 |
| Jun 30, 2019 | 6,003.00 |
| Mar 31, 2019 | 4,120.00 |
| Dec 31, 2018 | 4,330.00 |